LRSNF Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.08 - $0.08
Previous CloseN/A
Volume20.00
Average Volume (3M)N/A
Market Cap
$267.97K
Enterprise Value$3.16M
Total Cash (Recent Filing)$43.85K
Total Debt (Recent Filing)$2.78M
Price to Earnings (P/E)―
Beta0.00
Next Earnings
Dec 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding9,392,138
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.02
Price to Sales (P/S)1.97
P/FCF Ratio-0.16
Enterprise Value/Market Cap11.80
Enterprise Value/Revenue169.33
Enterprise Value/Gross Profit-11.64
Enterprise Value/Ebitda-2.94
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Modest Historical DebtHistorically modest absolute debt levels provided the company with greater financing flexibility and lower interest burden relative to peers. If management preserves this position or uses it to secure affordable capital, it lengthens runway while addressing structural turnaround needs.
Reduced Operating Cash Outflow TrendA smaller TTM operating cash outflow versus prior years signals partial stabilization in cash burn from operations. Sustaining this trend would improve liquidity dynamics, reduce near-term financing needs and indicate effective cost control or better working capital management over a multi-month horizon.
Losses Improved Vs Peak YearReported losses being smaller than the extreme 2021 level suggests management has taken steps that reduced the worst operating shortfalls. This improvement, if durable, provides a base for gradual margin recovery and reduces the immediacy of rescue financing requirements.
Bears Say
Shrinking RevenueA sustained ~39% TTM revenue decline erodes scale, reduces bargaining power with suppliers, and weakens ability to cover fixed costs. Persistent top-line contraction undermines long-term profitability prospects and increases reliance on external funding to sustain operations and any turnaround initiatives.
Negative Gross ProfitNegative gross profit means cost of goods sold exceeds revenue, indicating structural pricing, manufacturing or product-mix issues. This precludes sustainable operating profits because SG&A cuts alone cannot restore profitability unless unit economics or revenue mix materially improve.
Weak Balance Sheet And Negative EquityConsistent negative equity combined with rising debt and minimal reported assets sharply limits financial flexibility. It increases insolvency risk, raises cost or reduces availability of external capital, and likely forces dilution, asset sales, or restructuring to sustain operations over the medium term.
LRSNF FAQ
What was Global Health Clinics’s price range in the past 12 months?
Global Health Clinics lowest stock price was $0.08 and its highest was $0.08 in the past 12 months.
What is Global Health Clinics’s market cap?
Global Health Clinics’s market cap is $267.97K.
When is Global Health Clinics’s upcoming earnings report date?
Global Health Clinics’s upcoming earnings report date is Dec 01, 2026 which is in 121 days.
How were Global Health Clinics’s earnings last quarter?
Global Health Clinics released its earnings results on Jun 29, 2026. The company reported -$0.025 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.025.
Is Global Health Clinics overvalued?
According to Wall Street analysts Global Health Clinics’s price is currently Overvalued.
Does Global Health Clinics pay dividends?
Global Health Clinics does not currently pay dividends.
What is Global Health Clinics’s EPS estimate?
Global Health Clinics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Health Clinics have?
Global Health Clinics has 9,392,138 shares outstanding.
What happened to Global Health Clinics’s price movement after its last earnings report?
Global Health Clinics reported an EPS of -$0.025 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Global Health Clinics?
Currently, no hedge funds are holding shares in LRSNF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Global Health Clinics
Operating within the cannabis industry, Global Health Clinics Ltd. manages medical facilities that provide guidance to patients seeking to legally obtain and use marijuana. The company is also involved in creating psilocybin products designated for scientific research and pharmaceutical development. It was formerly known as Leo Resources Inc., changing its name to Global Health Clinics Ltd. in August 2018. Established in 2013, its primary operations are based in Vancouver, Canada.